Ratings by Jefferies (Chris Howerton)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/18/2024 | Apellis Pharmaceuticals | APLS | Maintain | Hold (N/A) |
|
Details | ||
| 8/11/2023 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 4/27/2023 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2023 | Acadia Pharmaceuticals | ACAD | Maintain | Underperform (N/A) |
|
Details | ||
| 3/14/2023 | Provention Bio Inc. | PRVB | Downgrade | Hold (Buy) |
6.70 (24.98) |
272.84% | Details | |
| 3/10/2023 | BioXcel Therapeutics | BTAI | Downgrade | Hold (Buy) |
28.36 (2.85) |
-89.95% | Details | |
| 2/28/2023 | Structure Therapeutics | GPCR | New Coverage | Buy (N/A) |
24.30 (36.02) |
48.23% | Details | |
| 2/27/2023 | Celldex Therapeutics | CLDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Prometheus Biosciences Inc | RXDX | New Coverage | Buy (N/A) |
119.04 (199.92) |
67.94% | Details | |
| 2/16/2023 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Tscan Therapeutics Inc | TCRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Alaunos Therapeutics Inc. | TCRT | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2023 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Protagonist Therapeutics | PTGX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Omega Therapeutics | OMGA | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Lava Therapeutics NV | LVTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Iveric Bio | ISEE | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2023 | IO Biotech | IOBT | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Werewolf Therapeutics Inc. | HOWL | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Compugen | CGEN | Downgrade | Underperform (Hold) |
0.98 (1.89) |
92.86% | Details | |
| 2/8/2023 | Avalo Therapeutics Inc. | AVTX | Downgrade | Underperform (Hold) |
3.49 (12.21) |
249.86% | Details | |
| 2/8/2023 | Apellis Pharmaceuticals | APLS | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2023 | AnaptysBio | ANAB | Maintain | Hold (N/A) |
|
Details | ||
| 2/8/2023 | Applied Molecular Transport | AMTI | Downgrade | Underperform (Hold) |
0.62 (0.26) |
-58.06% | Details | |
| 2/8/2023 | Veru, Inc. | VERU | Maintain | Underperform (Underperform) |
|
Details | ||
| 2/8/2023 | UroGen Pharma | URGN | Downgrade | Hold (Buy) |
9.23 (14.37) |
55.69% | Details | |
| 2/8/2023 | MEI Pharma | MEIP | Downgrade | Underperform (Hold) |
0.34 (3.37) |
891.18% | Details | |
| 2/8/2023 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Harmony Biosciences Holdings Inc. | HRMY | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2023 | Evelo Biosciences Inc | EVLO | Maintain | Underperform (N/A) |
|
Details | ||
| 2/8/2023 | Cara Therapeutics | CARA | Maintain | Buy (Buy) |
|
Details | ||
| 2/8/2023 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2023 | Evelo Biosciences Inc | EVLO | Downgrade | Underperform (Neutral) |
1.04 (0.32) |
-69.23% | Details | |
| 1/6/2023 | Landos Biopharma | LABP | Downgrade | Underperform (Hold) |
0.55 (21.96) |
3892.73% | Details | |
| 12/13/2022 | VectivBio Holding AG | VECT | New Coverage | Buy (N/A) |
7.97 (16.85) |
111.42% | Details | |
| 11/30/2022 | Avadel Pharmaceuticals | AVDL | Upgrade | Buy (Hold) |
7.84 (17.30) |
120.66% | Details | |
| 11/21/2022 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Veru, Inc. | VERU | Downgrade | Underperform (Buy) |
15.01 (1.27) |
-91.54% | Details | |
| 11/10/2022 | Iveric Bio | ISEE | Downgrade | Hold (Buy) |
20.52 (39.95) |
94.69% | Details | |
| 11/10/2022 | Apellis Pharmaceuticals | APLS | Downgrade | Hold (Buy) |
47.11 (47.64) |
1.13% | Details | |
| 10/14/2022 | Harmony Biosciences Holdings Inc. | HRMY | Upgrade | Buy (Hold) |
47.63 (29.35) |
-38.38% | Details | |
| 10/7/2022 | Provention Bio Inc. | PRVB | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Provention Bio Inc. | PRVB | New Coverage | Buy (N/A) |
5.05 (24.98) |
394.65% | Details | |
| 9/7/2022 | Iveric Bio | ISEE | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2022 | Alaunos Therapeutics Inc. | TCRT | Maintain | Hold (N/A) |
|
Details | ||
| 8/10/2022 | Avadel Pharmaceuticals | AVDL | Downgrade | Hold (Buy) |
6.31 (17.30) |
174.17% | Details | |
| 8/5/2022 | Compugen | CGEN | Downgrade | Hold (Buy) |
1.55 (1.89) |
21.94% | Details | |
| 8/3/2022 | Harmony Biosciences Holdings Inc. | HRMY | Downgrade | Hold (Buy) |
49.23 (29.35) |
-40.38% | Details | |
| 7/19/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Applied Molecular Transport | AMTI | Downgrade | Hold (Buy) |
3.12 (0.26) |
-91.67% | Details | |
| 7/6/2022 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2022 | Acadia Pharmaceuticals | ACAD | Downgrade | Underperform (Buy) |
19.51 (16.99) |
-12.92% | Details | |
| 5/26/2022 | POINT Biopharma Global Inc. | PNT | Upgrade | Buy (Hold) |
7.44 (12.50) |
68.01% | Details | |
| 5/17/2022 | Prometheus Biosciences Inc | RXDX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | Compugen | CGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/19/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2022 | Landos Biopharma | LABP | Downgrade | Hold (Buy) |
1.34 (21.96) |
1538.81% | Details | |
| 4/6/2022 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2022 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2022 | MEI Pharma | MEIP | Downgrade | Hold (Buy) |
1.80 (3.37) |
87.22% | Details | |
| 3/22/2022 | Iveric Bio | ISEE | New Coverage | Buy (N/A) |
16.76 (39.95) |
138.37% | Details | |
| 3/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2022 | Avalo Therapeutics Inc. | AVTX | Downgrade | Hold (Buy) |
0.78 (12.21) |
1465.38% | Details | |
| 3/2/2022 | Ardelyx, Inc | ARDX | Upgrade | Buy (Hold) |
0.77 (6.51) |
745.45% | Details | |
| 3/1/2022 | Gemini Therapeutics Inc. | GMTX | Downgrade | Hold (Buy) |
1.43 (1.35) |
-5.59% | Details | |
| 2/25/2022 | Vanda Pharmaceuticals | VNDA | Downgrade | Hold (Buy) |
13.07 (4.80) |
-63.27% | Details | |
| 2/3/2022 | MEI Pharma | MEIP | New Coverage | Buy (N/A) |
1.93 (3.37) |
74.61% | Details | |
| 1/28/2022 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2021 | Arena Pharma | ARNA | Downgrade | Hold (Buy) |
49.94 (99.98) |
100.2% | Details | |
| 12/13/2021 | IGM Biosciences | IGMS | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | IO Biotech | IOBT | New Coverage | Buy (N/A) |
8.74 (1.44) |
-83.52% | Details | |
| 11/16/2021 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2021 | Landos Biopharma | LABP | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | ZIOPHARM Oncology | ZIOP | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2021 | Liquidia Technologies | LQDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Viridian Therapeutic | VRDN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2021 | Evelo Biosciences Inc | EVLO | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | UroGen Pharma | URGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2021 | Celldex Therapeutics | CLDX | New Coverage | Buy (N/A) |
53.28 (38.85) |
-27.08% | Details | |
| 9/2/2021 | Veru, Inc. | VERU | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2021 | Omega Therapeutics | OMGA | New Coverage | Buy (N/A) |
21.83 (2.39) |
-89.05% | Details | |
| 8/23/2021 | Candel Therapeutics Inc. | CADL | New Coverage | Buy (N/A) |
5.75 (5.54) |
-3.65% | Details | |
| 8/19/2021 | Apellis Pharmaceuticals | APLS | New Coverage | Buy (N/A) |
57.91 (47.64) |
-17.73% | Details | |
| 8/10/2021 | Tscan Therapeutics Inc | TCRX | New Coverage | Buy (N/A) |
10.46 (7.12) |
-31.93% | Details | |
| 7/27/2021 | POINT Biopharma Global Inc. | PNT | New Coverage | Hold (N/A) |
9.00 (12.50) |
38.89% | Details | |
| 7/21/2021 | Ardelyx, Inc | ARDX | Downgrade | Hold (Buy) |
7.70 (6.51) |
-15.45% | Details | |
| 6/22/2021 | Seres Therapeutics | MCRB | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/25/2021 | Werewolf Therapeutics Inc. | HOWL | New Coverage | Buy (N/A) |
12.26 (6.09) |
-50.33% | Details | |
| 5/6/2021 | Chiasma | CHMA | Downgrade | Hold (Buy) |
2.84 (3.79) |
33.45% | Details | |
| 4/27/2021 | Axsome Therapeutics | AXSM | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2021 | Cerecor | CERC | New Coverage | Buy (N/A) |
2.51 (2.93) |
16.73% | Details | |
| 4/19/2021 | Lava Therapeutics NV | LVTX | New Coverage | Buy (N/A) |
15.62 (2.85) |
-81.75% | Details | |
| 4/12/2021 | Evelo Biosciences Inc | EVLO | Upgrade | Buy (Neutral) |
10.02 (0.32) |
-96.81% | Details | |
| 4/6/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Hold (Buy) |
25.59 (16.99) |
-33.61% | Details | |
| 4/1/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2021 | Applied Molecular Transport | AMTI | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2021 | ZIOPHARM Oncology | ZIOP | Downgrade | Hold (Buy) |
4.80 (0.87) |
-81.88% | Details | |
| 3/9/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2021 | Gemini Therapeutics Inc. | GMTX | New Coverage | Buy (N/A) |
15.60 (1.35) |
-91.35% | Details | |
| 3/1/2021 | Landos Biopharma | LABP | New Coverage | Buy (N/A) |
12.99 (21.96) |
69.05% | Details | |
| 2/16/2021 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Vanda Pharmaceuticals | VNDA | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2021 | Viridian Therapeutic | VRDN | New Coverage | Buy (N/A) |
0.00 (14.30) |
0% | Details | |
| 1/6/2021 | BioXcel Therapeutics | BTAI | Maintain | Buy (N/A) |
|
Details | ||
| 12/10/2020 | Pluristem Therapeutics | PSTI | Downgrade | Hold (Buy) |
7.00 (1.00) |
-85.71% | Details | |
| 12/3/2020 | Vanda Pharmaceuticals | VNDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2020 | Compugen | CGEN | New Coverage | Buy (N/A) |
17.95 (1.89) |
-89.47% | Details | |
| 10/6/2020 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2020 | Harmony Biosciences Holdings Inc. | HRMY | New Coverage | Buy (N/A) |
44.39 (29.35) |
-33.88% | Details | |
| 9/2/2020 | BioXcel Therapeutics | BTAI | New Coverage | Buy (N/A) |
40.75 (2.85) |
-93.01% | Details | |
| 8/13/2020 | Chiasma | CHMA | New Coverage | Buy (N/A) |
4.56 (3.79) |
-16.89% | Details | |
| 8/11/2020 | Bellerophon Therapeutics | BLPH | New Coverage | Buy (N/A) |
12.15 (0.10) |
-99.18% | Details | |
| 8/11/2020 | Avadel Pharmaceuticals | AVDL | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Seres Therapeutics | MCRB | Upgrade | Buy (Hold) |
4.64 (0.62) |
-86.64% | Details | |
| 8/7/2020 | TherapeuticsMD | TXMD | Downgrade | Underperform (Hold) |
2.05 (1.88) |
-8.29% | Details | |
| 8/6/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | Evelo Biosciences Inc | EVLO | Maintain | Hold (N/A) |
|
Details | ||
| 7/28/2020 | Seres Therapeutics | MCRB | Maintain | Hold (N/A) |
|
Details | ||
| 7/24/2020 | Pluristem Therapeutics | PSTI | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2020 | Milestone Pharmaceuticals | MIST | Upgrade | Buy (Hold) |
3.34 (1.63) |
-51.2% | Details | |
| 7/21/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2020 | Protagonist Therapeutics | PTGX | New Coverage | Buy (N/A) |
15.19 (26.61) |
75.18% | Details | |
| 6/30/2020 | Applied Molecular Transport | AMTI | New Coverage | Buy (N/A) |
26.15 (0.26) |
-99.01% | Details | |
| 6/23/2020 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 6/19/2020 | ZIOPHARM Oncology | ZIOP | New Coverage | Buy (N/A) |
3.24 (0.87) |
-73.15% | Details | |
| 6/19/2020 | Pluristem Therapeutics | PSTI | New Coverage | Buy (N/A) |
7.35 (1.00) |
-86.39% | Details | |
| 5/22/2020 | Arena Pharma | ARNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2020 | Arena Pharma | ARNA | New Coverage | Buy (N/A) |
45.26 (99.98) |
120.9% | Details | |
| 5/12/2020 | Evelo Biosciences Inc | EVLO | Downgrade | Hold (Buy) |
5.48 (0.32) |
-94.16% | Details | |
| 4/16/2020 | Acadia Pharmaceuticals | ACAD | New Coverage | Buy (N/A) |
44.93 (16.99) |
-62.19% | Details | |
| 4/3/2020 | Avadel Pharmaceuticals | AVDL | New Coverage | Buy (N/A) |
7.34 (17.30) |
135.69% | Details | |
| 3/25/2020 | Milestone Pharmaceuticals | MIST | Downgrade | Hold (Buy) |
14.00 (1.63) |
-88.36% | Details | |
| 2/18/2020 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
7.68 (6.51) |
-15.23% | Details | |
| 9/24/2019 | Strongbridge Biopharma | SBBP | New Coverage | Buy (N/A) |
2.41 (2.00) |
-17.01% | Details | |
| 9/24/2019 | Strongbridge Biopharma | SBBP | New Coverage | Buy (N/A) |
2.68 (2.41) |
-10.07% | Details | |
| 9/24/2019 | Corcept Therapeutics | CORT | New Coverage | Buy (N/A) |
14.09 (22.30) |
58.27% | Details | |
| 8/21/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2019 | TG Therapeutics | TGTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2019 | Milestone Pharmaceuticals | MIST | New Coverage | Buy (N/A) |
21.16 (14.00) |
-33.84% | Details | |
| 5/29/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 4/30/2019 | Synlogic Inc. | SYBX | New Coverage | Buy (N/A) |
7.71 (1.84) |
-76.13% | Details | |
| 4/30/2019 | Seres Therapeutics | MCRB | New Coverage | Hold (N/A) |
7.35 (0.62) |
-91.56% | Details | |
| 4/30/2019 | Evelo Biosciences Inc | EVLO | New Coverage | Buy (N/A) |
8.21 (5.48) |
-33.25% | Details | |
| 2/27/2019 | Cara Therapeutics | CARA | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2019 | TG Therapeutics | TGTX | New Coverage | Buy (N/A) |
4.04 (23.60) |
484.16% | Details | |
| 2/6/2019 | Sesen Bio, Inc | SESN | New Coverage | Buy (N/A) |
0.82 (0.63) |
-23.17% | Details | |
| 2/6/2019 | Cara Therapeutics | CARA | New Coverage | Buy (N/A) |
15.37 (0.73) |
-95.25% | Details | |
| 12/3/2018 | Vanda Pharmaceuticals | VNDA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2018 | Liquidia Technologies | LQDA | New Coverage | Buy (N/A) |
18.70 (13.18) |
-29.52% | Details | |
| 11/8/2018 | UroGen Pharma | URGN | New Coverage | Buy (N/A) |
43.78 (14.37) |
-67.18% | Details | |
| 11/8/2018 | Allena Pharmaceuticals | ALNA | New Coverage | Buy (N/A) |
7.68 (0.08) |
-98.96% | Details |
